BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2276046)

  • 1. Striatonigral degeneration. A clinicopathological study.
    Fearnley JM; Lees AJ
    Brain; 1990 Dec; 113 ( Pt 6)():1823-42. PubMed ID: 2276046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel grading scale for striatonigral degeneration (multiple system atrophy).
    Wenning GK; Seppi K; Tison F; Jellinger K
    J Neural Transm (Vienna); 2002 Mar; 109(3):307-20. PubMed ID: 11956953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of late onset striatonigral degeneration.
    Przedborski S; Schiffmann SN; Monseu G; Maloteaux JM; Flament-Durand J
    Acta Neurol Belg; 1989; 89(1):29-37. PubMed ID: 2508411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms?
    Jellinger KA
    J Neural Transm Suppl; 1999; 56():1-29. PubMed ID: 10370901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic Parkinson's disease combined with multiple system atrophy. A clinicopathological report.
    Hughes AJ; Daniel SE; Lees AJ
    Mov Disord; 1991; 6(4):342-6. PubMed ID: 1758453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
    Perani D; Bressi S; Testa D; Grassi F; Cortelli P; Gentrini S; Savoiardo M; Caraceni T; Fazio F
    Arch Neurol; 1995 Feb; 52(2):179-85. PubMed ID: 7848128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin immunoreactivity in striatonigral degeneration.
    Goto S; Hirano A; Rojas-Corona RR
    Acta Neuropathol; 1989; 78(1):65-71. PubMed ID: 2544073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatonigral degeneration: clinical, MRI, and pathologic correlation.
    O'Brien C; Sung JH; McGeachie RE; Lee MC
    Neurology; 1990 Apr; 40(4):710-1. PubMed ID: 2320250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque.
    Hedreen JC; DeLong MR
    J Comp Neurol; 1991 Feb; 304(4):569-95. PubMed ID: 2013650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatopallidonigral degeneration in Pick's disease: a clinicopathological study of 41 cases.
    Kosaka K; Ikeda K; Kobayashi K; Mehraein P
    J Neurol; 1991 Jun; 238(3):151-60. PubMed ID: 1869891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple system atrophy: a review of 203 pathologically proven cases.
    Wenning GK; Tison F; Ben Shlomo Y; Daniel SE; Quinn NP
    Mov Disord; 1997 Mar; 12(2):133-47. PubMed ID: 9087971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [L-dopa-resistant Parkinson's disease with cerebral atrophy: striato-nigral degeneration?].
    Dell'Aria V; Ciannella L; Melone MA
    Acta Neurol Quad (Napoli); 1981; 42():212-5. PubMed ID: 7270052
    [No Abstract]   [Full Text] [Related]  

  • 13. Striatonigral degeneration.
    Kan AE
    Pathology; 1978 Jan; 10(1):45-52. PubMed ID: 643319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathology of the substantia nigra.
    Gibb WR
    Eur Neurol; 1991; 31 Suppl 1():48-59. PubMed ID: 1830274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-field MR findings of multiple system atrophy].
    Tsuchiya K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jul; 50(7):772-9. PubMed ID: 2235325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?
    Ling H; Kearney S; Yip HL; Silveira-Moriyama L; Revesz T; Holton JL; Strand C; Davey K; Mok KY; Polke JM; Lees AJ
    J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):633-41. PubMed ID: 26209716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson's Disease Stages?
    Hopes L; Grolez G; Moreau C; Lopes R; Ryckewaert G; Carrière N; Auger F; Laloux C; Petrault M; Devedjian JC; Bordet R; Defebvre L; Jissendi P; Delmaire C; Devos D
    PLoS One; 2016; 11(4):e0147947. PubMed ID: 27035571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
    Brooks DJ; Salmon EP; Mathias CJ; Quinn N; Leenders KL; Bannister R; Marsden CD; Frackowiak RS
    Brain; 1990 Oct; 113 ( Pt 5)():1539-52. PubMed ID: 2123119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.